학술논문
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes
Document Type
Article
Source
In: Diabetes, Obesity and Metabolism . (Diabetes, Obesity and Metabolism, 1 November 2019, 21(11):2496-2504)
Subject
Language
English
ISSN
14631326
14628902
14628902